Combined training is the most effective training modality to improve aerobic capacity and blood pressure control in people requiring haemodialysis for end-stage renal disease: systematic review and network meta-analysis

Imagem de Miniatura
Arquivos
art_SCAPINI_Combined_training_is_the_most_effective_training_modality_2019.PDF (655 KB)
Citações na Scopus
45
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AUSTRALIAN PHYSIOTHERAPY ASSOC
Autores
BOHLKE, Maristela
RODRIGUES, Clarissa G.
INACIO, Jose F. S.
SBRUZZI, Graciele
LEGUISAMO, Camila P.
SANCHES, Iris C.
TOURINHO FILHO, Hugo
Citação
JOURNAL OF PHYSIOTHERAPY, v.65, n.1, p.4-15, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Questions: Do aerobic, resistance and combined exercise training improve aerobic capacity, arterial blood pressure and haemodialysis efficiency in people requiring haemodialysis for end-stage renal disease? Is one exercise training modality better than the others for improving these outcomes? Design: Systematic review with network meta-analysis of randomised trials. Participants: Adults requiring haemodialysis for end-stage renal disease. Intervention: Aerobic training, resistance training, combined training and control (no exercise or placebo). Outcome measures: Aerobic capacity, arterial blood pressure at rest, and haemodialysis efficiency. Results: Thirty-three trials involving 1254 participants were included. Direct meta-analyses were conducted first. Aerobic capacity improved significantly more with aerobic training (3.35 ml/kg/min, 95% CI 1.79 to 4.91) and combined training (5.00 ml/kg/min, 95% CI 3.50 to 6.50) than with control. Only combined training significantly reduced systolic (-9 mmHg, 95% CI - 13 to -4) and diastolic (-5 mmHg, 95% CI -6 to -3) blood pressure compared to control. Only aerobic training was superior to control for haemodialysis efficiency (Kt/V 0.11, 95% CI 0.02 to 0.20). However, when network meta-analysis was conducted, there were some important different findings. Both aerobic training and combined training again elicited greater improvements in aerobic capacity than control. For systolic blood pressure, combined training was superior to control. For diastolic blood pressure, combined training was superior to aerobic training and control. No modality was superior to control for haemodialysis efficiency. Combined training was ranked as the most effective treatment for aerobic capacity and arterial blood pressure. Conclusion: Combined training was the most effective modality to increase aerobic capacity and blood pressure control in people who require haemodialysis. This finding helps to fill the gap created by the lack of head-to-head comparisons of different modalities of exercise in people with end-stage renal disease. (C) 2018 Australian Physiotherapy Association.
Palavras-chave
Chronic kidney failure, Renal dialysis, Exercise, Network meta-analysis, Physical therapy
URI
https://observatorio.fm.usp.br/handle/OPI/30981
Referências
  1. Abreu CC, 2017, LIFE SCI, V188, P192, DOI 10.1016/j.lfs.2017.09.007
  2. Afshar R, 2010, Indian J Nephrol, V20, P185, DOI 10.4103/0971-4065.73442
  3. Akiba T, 1995, ARTIF ORGANS, V19, P1262, DOI 10.1111/j.1525-1594.1995.tb02297.x
  4. CARNEY RM, 1987, NEPHRON, V47, P194, DOI 10.1159/000184490
  5. Cheema B, 2007, AM J KIDNEY DIS, V50, P574, DOI 10.1053/j.ajkd.2007.07.005
  6. Cheema B, 2007, J AM SOC NEPHROL, V18, P1594, DOI 10.1681/ASN.2006121329
  7. Deligiannis A, 1999, INT J CARDIOL, V70, P253, DOI 10.1016/S0167-5273(99)00090-X
  8. Deligiannis A, 1999, AM J CARDIOL, V84, P197, DOI 10.1016/S0002-9149(99)00234-9
  9. DePaul V, 2002, AM J KIDNEY DIS, V40, P1219, DOI 10.1053/ajkd.2002.36887
  10. Dobsak P, 2012, ARTIF ORGANS, V36, P71, DOI 10.1111/j.1525-1594.2011.01302.x
  11. Farese S, 2008, AM J KIDNEY DIS, V52, P745, DOI 10.1053/j.ajkd.2008.03.017
  12. Frey S, 1999, J Ren Nutr, V9, P71, DOI 10.1016/S1051-2276(99)90003-1
  13. Frih B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00288
  14. Goldberg A P, 1983, Kidney Int Suppl, V16, pS303
  15. GOLDBERG AP, 1986, NEPHRON, V42, P311, DOI 10.1159/000183694
  16. Groussard C, 2015, APPL PHYSIOL NUTR ME, V40, P550, DOI 10.1139/apnm-2014-0357
  17. HARTER HR, 1985, MED CLIN N AM, V69, P159, DOI 10.1016/S0025-7125(16)31063-X
  18. Heiwe S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003236.pub2
  19. Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI 10.1002/9780470712184
  20. Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765
  21. Iberati A, 2009, BMJ-BRIT MED J, V339, pb2700, DOI 10.1136/BMJ.B2700
  22. Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X
  23. Koh KP, 2010, AM J KIDNEY DIS, V55, P88, DOI 10.1053/j.ajkd.2009.09.025
  24. Konstantinidou E, 2002, J REHABIL MED, V34, P40, DOI 10.1080/165019702317242695
  25. Kopple JD, 2007, J AM SOC NEPHROL, V18, P2975, DOI 10.1681/ASN.2006070794
  26. Kouidi E, 1997, NEPHRON, V77, P152, DOI 10.1159/000190266
  27. Kouidi E, 2010, EUR J CARDIOV PREV R, V17, P160, DOI 10.1097/HJR.0b013e32833188c4
  28. Kouidi EJ, 2009, AM J KIDNEY DIS, V54, P511, DOI 10.1053/j.ajkd.2009.03.009
  29. Liao MT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004134
  30. Mohseni Raheleh, 2013, Oman Med J, V28, P345, DOI 10.5001/omj.2013.99
  31. Molsted S, 2004, NEPHRON CLIN PRACT, V96, P76, DOI 10.1159/000076744
  32. Moros M T, 1995, Rev Med Univ Navarra, V39, P136
  33. O'Hare AM, 2003, AM J KIDNEY DIS, V41, P447, DOI 10.1053/ajkd.2003.50055
  34. Olsen MH, 2015, LANCET, V386, P637, DOI 10.1016/S0140-6736(15)61178-3
  35. Orcy R, 2014, HEMODIAL INT, V18, P450, DOI 10.1111/hdi.12123
  36. Ouzouni S, 2009, CLIN REHABIL, V23, P53, DOI 10.1177/0269215508096760
  37. Painter P, 2002, AM J KIDNEY DIS, V39, P257, DOI 10.1053/ajkd.2002.30544
  38. Parsons TL, 2004, CLIN NEPHROL, V61, P261
  39. Petraki M, 2008, CLIN NEPHROL, V70, P210
  40. Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1
  41. Reboredo Maycon de Moura, 2010, J Bras Nefrol, V32, P367
  42. Reboredo MM, 2015, EUR J PREV CARDIOL, V22, P912, DOI 10.1177/2047487314543079
  43. Reboredo MM, 2011, ARCH PHYS MED REHAB, V92, P2018, DOI 10.1016/j.apmr.2011.07.190
  44. Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150
  45. Saran R, 2004, AM J KIDNEY DIS, V44, pS47, DOI 10.1053/j.ajkd.2004.08.011
  46. Schwingshackl L, 2014, DIABETOLOGIA, V57, P1789, DOI 10.1007/s00125-014-3303-z
  47. Schwingshackl L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082853
  48. Sheng KX, 2014, AM J NEPHROL, V40, P478, DOI 10.1159/000368722
  49. Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x
  50. Stack AG, 2005, AM J KIDNEY DIS, V45, P690, DOI 10.1053/j.ajkd.2004.12.013
  51. Tentori F, 2010, NEPHROL DIAL TRANSPL, V25, P3050, DOI 10.1093/ndt/gfq138
  52. Thompson S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012085
  53. Toussaint ND, 2008, HEMODIAL INT, V12, P254, DOI 10.1111/j.1542-4758.2008.00262.x
  54. Tsuyuki K, 2003, THER APHER DIAL, V7, P461, DOI 10.1046/j.1526-0968.2003.00084.x
  55. Vaithilingam I, 2004, AM J KIDNEY DIS, V43, P85, DOI 10.1053/j.ajkd.2003.09.016
  56. van Vilsteren MCBA, 2005, NEPHROL DIAL TRANSPL, V20, P141, DOI 10.1093/ndt/gfh560
  57. Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
  58. Wilund KR, 2010, NEPHROL DIAL TRANSPL, V25, P2695, DOI 10.1093/ndt/gfq106
  59. Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/59